Table 1.
Characteristics of patients in our cohort
| No. | Age at BC dx | BMI at BC dx | Stage | ER + | PR + | HER2 + | BC surety | CT | CT regimen | RT | ET | Age at BS | Yrs from BC dx to BS | BMI at BS | Type of BS | Post-op complications from BS | % wt loss in 1 yr | % wt loss in 2 yrs | BC recurrence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 50 | 32.6 | IA | Y | N | N | Right lumpectomy | N | – | Y | Y | 56 | 6.0 | 37.1 | Lap sleeve gastrectomy | None | 23.5 | 20.2 | N |
| 2 | 30 | 52.6 | HA | N | N | N | Bilateral mastectomies | Y | Doxorubicin + cyclophosphamide then paclitaxel | N | N | 33 | 3.0 | 52.3 | Lap adjustable gastric band | None | 18.7 | 18.7 | N |
| 3 | 47 | 37.8 | IA | Y | Y | N | Left lumpectomy | Y | Doxorubicin + cyclophosphamide | Y | Y | 52 | 5.5 | 43 | Lap sleeve gastrectomy | None | 26.5 | 26.0 | N |
| 4 | 57 | 39.4 | IA | Y | Y | N | Bilateral mastectomies | N | – | N | Y | 59 | 2.7 | 38.9 | Lap Roux-en-Y gastric bypass | Abdominal wall hematoma | 14.7 | 10.8 | N |
| 5 | 35 | NA | HA | Y | Y | N | Left mastectomy | Y | Cyclophosphamide + methotrexate +5-fluorouracil | N | Y | 43 | 7.5 | 40.2 | Lap Roux-en-Y gastric bypass | None | 31.6 | 36.8 | Y |
| 6 | 50 | 31.0 | IA | Y | Y | N | Bilateral mastectomies | Y | Cyclophosphamide + paclitaxel | N | Y | 52 | 2.3 | 36.4 | Lap sleeve gastrectomy | None | 40.1 | 37.9 | N |
| 7 | 36 | 36.9 | IA | Y | Y | Y | Right lumpectomy | Y | Doxorubicin + cyclophosphamide | Y | Y | 45 | 9.2 | 39.3 | Lap sleeve gastrectomy | None | 21.1 | 19.8 | N |
| 8 | 42 | 35.0 | HA | Y | Y | N | Left lumpectomy | Y | Paclitaxel then doxorubicin + cyclophosphamide | Y | Y | 43 | 1.3 | 36.6 | Lap sleeve gastrectomy | None | 35.8 | 24.3 | N |
| 9 | 42 | 44.0 | IA | Y | Y | N | Bilateral mastectomies | N | – | N | Y | 43 | 1.1 | 42.4 | Lap Roux-en-Y gastric bypass | None | 33.5 | 46.7 | N |
| 10 | 41 | 44.3 | IA | Y | Y | N | Bilateral mastectomies | Y | Cyclophosphamide + methotrexate +5-fluorouracil | N | Y | 44 | 2.2 | 46.9 | Lap Roux-en-Y gastric bypass | None | 35.0 | 43.5 | N |
| 11 | 53 | 43.7 | IA | Y | Y | N | Right lumpectomy | N | – | Y | Y | 56 | 2.4 | 43.8 | Lap Roux-en-Y gastric bypass | None | 29.2 | 28.8 | N |
| 12 | 42 | NA | NA | NA | NA | NA | Left lumpectomy | Y | NA | Y | NA | 55 | 13.3 | 38.2 | Lap duodenal switch | None | 38.0 | 38.7 | N |
| 13 | 49 | NA | IA | N | N | N | Bilateral mastectomies | Y | NA | N | N | 63 | 14.2 | 33.8 | Lap Roux-en-Y gastric bypass | None | 17.5 | 14.2 | N |
BC, breast cancer; BMI, body mass index; BS, bariatric surgery; CT, chemotherapy, dx, diagnosis; ET, endocrine therapy, lap, laparoscopic; NA, not available; RT, radiation therapy, wt, weight; yr, year